Sign up | Login with →

cancer

Colon Cancer Diagnosed at Earlier Ages

February 2, 2016 by Liz Seegert

Colorectal cancer is the third most commonly diagnosed cancer and second leading cause of cancer deaths in the United States. Disease risk increases with age, but those of certain ethnic backgrounds are being diagnosed with the condition at younger ages than ever before, say authors of a new study from the University of Missouri School of Medicine.[read more]

2015: Reflecting Upon Cancer Wins and Losses

December 31, 2015 by Andrew Schorr

As the year ends, we ask ourselves, how has it been, and are we hopeful going into the next? My feeling as I reflect is that 2015, when it comes to cancer, was a year of significant progress. But that is always tempered with the losses.[read more]

ASH 2015: A Cancer Community of Hope

December 10, 2015 by Andrew Schorr

A report from the American Society of Hematology meeting in Orlando. May attendees walked away hopeful with the news that cancer seems to be "on the run." First on the list is multiple myeloma: five new drugs were approved this past year and three in the past three weeks. They are effective, and new combinations are sure to have people living longer and better. Tangible Hope.[read more]

Maintaining Hope and Positivity Through Life’s “Ripples”

December 5, 2015 by Andrew Schorr
1

To me, “ripples” are events that change your life for a period of time until life goes back to “normal” or the “new normal.” Ripples can be surgeries, deaths, life changes, illness, etc. I experienced a major life “ripple” when I was diagnosed with cervical lymphoma eight years ago. So when your life has a ripple moment, how do you keep hope alive?[read more]

Has CLL Defined Me?

November 22, 2015 by Andrew Schorr

I had responded initially “no” because of the way I am able to live my life. Since 2010, I haven’t needed treatment. The only pill I take is vitamin D3 when I remember. I continue to work as a communications consultant and a medical journalist. I travel when and where I want. I have visited more than a dozen countries since my original diagnosis. Sounds like “no,” doesn’t it?[read more]

exclusive

The Future of Ovarian Cancer Diagnosis Is Now — Through These 4 Strategies

November 11, 2015 by Judy Wolf

Significant improvements to the way ovarian cancer is screened, diagnosed, and treated are at our fingertips. These four strategies, however, will put them in our palms.[read more]

Healthcare at the GOP debate

November 3, 2015 by David E Williams
1

A synopsis of where the GOP candidates stand when it comes to healthcare: the good, the bad, and the neutral. Who do you agree with?[read more]

The Emotional Side of Cancer

November 3, 2015 by Andrew Schorr

An inspiring letter from a two-time survivor of pancreatic cancer. "In my cancer fight, I made a deliberate, difficult decision to stay upbeat."[read more]

Financial Assistance for Clinical Trials

September 16, 2015 by Joan Justice
2

Sometimes hospitals, research centers and pharmaceutical companies will cover the cost of treatment in a clinical trial. However, if the treatment is experimental or investigational, a patient may not receive insurance coverage. Insurance companies generally will cover what is considered the standard of care for a disease.[read more]

Clinical Trials Process: A Physician's View

September 8, 2015 by Joan Justice
1

Dr. Jeff Sharman

Dr. Sharman is convinced that although research adds to a physician’s workload, it enlivens a practice and adds to productivity[read more]

Frank Discussions About Oral Cancer Therapies

June 8, 2015 by Andrew Schorr

Oral cancer therapies seem poised to revolutionize cancer care for many cancer types. More convenient, more effective, and often less toxic. But they are quite expensive—in many cases, more than $100,000 a year per patient. And some experts have been discussing combining two drugs. We must talk more about cost and not just echo the mantra of researchers who are “excited” about trial results.[read more]

Schmoozing for Cancer, Part II

May 20, 2015 by Andrew Schorr

If you become part of the Patient Power community, we don’t schmooze with you once but all the time. It’s the way we interact. And we believe it’s unique. We talk with people, not at them, and we want to know everyone’s story. That’s why our town meetings are not seminars, they are conversations.[read more]

levitra online